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We describe a programme for the prevention of mother-to-child transmission (PMTCT) of HIV that provided universal
antiretroviraltherapy(ART)toallpregnantwomenregardlessoftheCD4lymphocytecountandformulafeedingforchildrenwith
highriskofHIVtransmissionthroughbreastfeedinginadistrictofIndia.TheoverallrateofHIVtransmissionwas3.7%.Although
breastfeeding added a 3.1% additional risk of HIV acquisition, formula-fed infants had signiﬁcantly higher risk of death compared
to breastfed infants. The cumulative 12-month mortality was 9.6% for formula-fed infants versus 0.68% for breastfed infants.
Anthropometric markers (weight, length/height, weight for length/height, body mass index, head circumference, mid-upper arm
circumference, triceps skinfold, and subscapular skinfold) showed that formula-fed infants experience severe malnutrition during
theﬁrsttwomonthsoflife.Wedidnotobserveanydeathafterrapidweaningat5-6monthsinbreastfedinfants.Thehigher-free-of
HIV survival in breastfed infants and the low rate of HIV transmission found in this study support the implementation of PMTCT
programmes with universal ART to all HIV-infected pregnant women and breastfeeding in order to reduce HIV transmission
without increasing infant mortality in developing countries.
1.Background
In 2010, there were 1,490,000 HIV-infected pregnant women
and390,000childrenbecameinfectedwithHIV[1].Mother-
to-child transmission of HIV can occur during pregnancy,
during birth, or during breastfeeding. The risk of trans-
mission is 15–30% in nonbreastfeeding populations and
breastfeeding adds an additional 5–20% risk for an overall
transmission rate of 20−45% [2]. In 2010, the World Health
Organization (WHO) released the guidelines on antiretrovi-
ral drugs for treating pregnant women and preventing HIV
infectionininfantswiththegoalofreducingmother-to-child
transmission to less than 5% and virtually eliminating HIV
infection in children by 2015 [3, 4].
Infant feeding by HIV-infected women remains a public
health dilemma for developing countries. Although breast-
feeding involves a considerable risk of HIV transmission,
nonbreastfed infants are exposed to higher risk of death
in resource-limited setting [5, 6]. According to 2010 WHO
guidelines [4], National health authorities should decide
whether health services will principally counsel and sup-
port HIV-infected women to either breastfeed and receive
antiretroviral interventions or avoid breastfeeding, as the
strategy that will most likely give infants the greatest chance2 ISRN Pediatrics
of HIV-free survival. Developed countries have decided to
recommend formula feeding for HIV-exposed children due
to the low infant mortality and the risk of HIV transmission
through breastfeeding, whereas in developing countries the
health and survival beneﬁts of breastfeeding exceed the risk
of HIV transmission [7]. However, most of the evidence for
recommending breastfeeding in developing countries comes
from clinical trials performed in Sub-Saharan Africa. Data
of formula feeding on child growth and mortality from
PMTCT programmes in other continents are scarce, and
some developing countries are supporting the use of formula
feeding in their national PMTCT programmes [7–11].
India is the third country in the world in terms of HIV
infected people, and it is estimated that 43,000 pregnant
women were living with HIV in India in 2009 [12]. In
this study, we investigated the eﬀect of formula feeding and
breastfeeding on mortality, growth, and HIV transmission of
children enrolled in a PMTCT programme in a rural district
of India.
2. Methods
2.1. Setting. In India, the neonatal mortality rate was 34
deaths/1000 live births and the infant mortality rate was 50
deaths/1000 live births in 2009 [13]. Andhra Pradesh is the
statewiththehighestburdenofHIV-infectedpeopleinIndia
[14]. Anantapur is a district situated in the south border
of Andhra Pradesh. Rural Development Trust (RDT) is a
nongovernmental organization that has three hospitals in
Anantapur. In these hospitals, medical care of HIV-infected
people is provided free of cost, including medicines and
consultation or admission charges.
The Vicente Ferrer HIV Cohort Study (VFHCS) is an
open cohort study of all HIV-infected patients who have
visitedtheRDThospitalssinceJune2006.Thecharacteristics
ofthecohorthavebeendescribedelsewhere[15].Takinginto
account data from the Andhra Pradesh State AIDS Control
Society that estimates that 15,721 HIV-infected people are
living in the district of Anantapur, the cohort is fairly
representative for the district as it covers approximately 70%
ofallHIV-infectedpatients[15].Forthisstudy,HIV-infected
women from the VFHCS database who became pregnant
between January 1st 2008 and December 5th 2010 were
included in the analysis. The selection of patients from the
database was executed in January 17th 2012.
2.2. Description of the RDT Programme for PMTCT of HIV.
In order to reduce the number of children infected by
HIV, RDT initiated a programme for PMTCT. In close
collaborationwithgovernmentalIntegrated Counselling and
Testing Centres, which provided free HIV testing to all
pregnant women in the district, HIV-positive pregnant
women were followed by a group of 30 community health
workers spread across the district. HIV-infected pregnant
women initiated triple antiretroviral therapy (ART) regard-
less of the CD4 lymphocyte count. Delivery by caesarean
section was oﬀered to all women for reducing the risk
of HIV transmission at birth, unless they had an HIV
viral load below 1000copies/mL in the third trimester of
pregnancy. In women who were diagnosed with HIV during
labour, a single ﬁxed-dose combination tablet of zidovudine
300mg, lamivudine 150mg, and nevirapine 200mg was
given, and caesarean section was performed only if there was
no membrane rupture. Exclusive breastfeeding with rapid
weaning after 5-6 months was promoted. However, women
who initiated ART less than one month before delivery
were counselled about the risk of HIV transmission through
breastfeedingandformulafeedingwasoﬀeredforsixmonths
free of cost. Women who decided to give formula feeding to
their babies were admitted to hospital for training on safe
methods of replacement feeding such as boiling water for
milk preparation and using cup feeding instead of bottle
feeding [2,16]. ARTto the mother wascontinued afterdeliv-
ery if the CD4 lymphocyte count was below 350cells/µLa t
the moment of initiating ART. In women who initiated ART
with high CD4 lymphocyte count, ART was stopped either
one month after stopping breastfeeding or immediately
after delivery in those women who decided to give formula
feeding to their children. If the ART regiment included a
nonnucleoside reverse transcriptase inhibitor (nevirapine or
efavirenz), two nucleoside reverse transcriptase inhibitors
were continued for two extra weeks in order to reduce the
risk of developing nevirapine or efavirenz resistance due to
their longer life span [4].
Newborn prophylaxis was also given. Before the publi-
cation of the WHO 2010 guidelines, single (zidovudine or
nevirapine) or triple (zidovudine, lamivudine, and nevirap-
ine) drug prophylaxis in syrup form was given to newborns
for 7 to 42 days according to the risk of HIV infection during
delivery. After the publication of WHO 2010 guidelines, all
newborns received 28 days of zidovudine syrup according to
their weight.
For identifying the moment of HIV transmission, we
aimed to perform HIV viral load at birth, after six weeks
of delivery and after six weeks of stopping breastfeeding.
Children were considered to be infected intrauterus, during
delivery, or during breastfeeding if the HIV viral load was
positive at birth, after six weeks of delivery, or six weeks
after stopping breastfeeding, respectively. Children who did
not have any HIV viral load determination were considered
as HIV negative if their HIV serology was negative at any
time after six months of age and were considered as HIV
positive if they had a positive HIV serology after 18 months
of age [17]. Measurement of HIV viral load was performed
utilizing two diﬀerent commercial assays, a real-time HIV-
1 RNA polymerase chain reaction assay (Cobas TaqMan
HIV-1 v1.0, Roche Diagnostics, Mannheim, Germany) until
March 2011 and a reverse transcriptase activity assay (Exavir
load version 3, Cavidi, Uppsala, Sweden) since March
2011.
During the visits of children to hospitals, growth param-
eterssuchasweight,length/height,headcircumference,mid-
upper arm circumference, triceps skinfold thickness and
subscapular skinfold thickness were collected. HIV-exposed
children were followed up until 18 months of age with reg-
ular visits to the hospitals and with home visits by outreach
workers.ISRN Pediatrics 3
Table 1: Characteristics of patients enrolled in the programme
before delivery.
N (%)
Age 23.5 (21–25.2)∗
Height 152 (148–160)∗
Underweight (BMI < 18.5) 122 (39)
First pregnancy 173 (51.49)
Education
Higher 13 (3.88)
Secondary 128 (38.21)
Primary 48 (14.33)
No education 146 (43.58)
Smoker 1 (0.003)
CD4 lymphocyte count (cells/µL)
<200 29 (8.76)
200–350 96 (29)
350–500 102 (30.82)
>500 104 (31.42)
Time on ART before delivery
<1 day 23 (6.91)
1–30 days 53 (15.92)
31–60 days 48 (14.41)
61–90 days 54 (16.22)
91–120 days 40 (12.01)
>120 days 115 (34.53)
ART regimen
AZT + 3TC + NVP 148 (44.05)
AZT + 3TC + EFV 68 (20.24)
AZT + 3TC + NFV 35 (10.42)
D4T + 3TC + NVP 39 (11.61)
D4T + 3TC + EFV 19 (5.65)
D4T + 3TC + NFV 16 (4.76)
TDF + 3TC/FTC + LPVr 5 (1.49)
AZT + 3TC + LPVr 4 (1.19)
d4T + 3TC + LPVr 1 (0.3)
TDF + 3TC + AZT 1 (0.3)
Home delivery 24 (7.38)
Caesarean section 125 (39.18)
Newborn prophylaxis
AZT 229 (73.63)
AZT + 3TC + NVP 59 (18.97)
NVP 15 (4.82)
None 8 (2.57)
Type of feeding
Formula 159 (51.29)
Breast 148 (47.74)
Mixed 3 (0.97)
∗Median (interquartile range). BMI: body mass index; ART: antiretroviral
treatment; AZT: zidovudine; 3TC: lamivudine; NVP, and nevirapine; EFV,
efavirenz; d4T: stavudine; NFV: nelﬁnavir; TDF: tenofovir; FTC: emtricita-
bine; LPVr: lopinavir-ritonavir. Missing values for each variable were not
included.
2.3. Statistical Analysis. Statistical analysis was performed
using Stata Statistical Software (Stata Corporation, Release
11, College Station, Texas, USA). Conﬁdence intervals for
proportions were estimated utilizing the Wilson method
[18]. We used Kaplan-Meier curves and log-rank test for
comparing mortality in children who received breastfeeding
or formula feeding. Time was measured from birth to
death or the last visit date. For calculating Z-scores of
anthropometric indicators according to WHO child growth
standards for age and sex, we utilized the WHO macro
for Stata (igrowup standard.ado) [19]. WHO child growth
standards were calculated from a group of selected children
from diﬀerent parts of the world who received optimal
nutrition according to WHO standards: no known health
or environmental constraints to growth, mothers willing
to follow speciﬁc feeding recommendations (i.e., exclusive
or predominant breastfeeding for at least four months,
introduction of complementary foods by the age of six
months and continued partial breastfeeding up to at least
12 months), no maternal smoking before and after delivery,
single term birth, and absence of signiﬁcant morbidity
[20]. Among all anthropometric markers, we selected severe
underweight (weight-for-age < −3 Z-scores) because it has
demonstrated to be a good indicator for predicting mortality
in infants from India, especially in infants aged less than
six months [21]. The study was approved by the ethical
committee of the RDT Institutional Review Board.
3. Results
During the study period, 391 HIV-infected pregnant women
were identiﬁed and 336 (85.9%) entered in the PMTCT
programme before delivery. Of the 55 pregnancies that did
not enter in the programme before delivery, ﬁve children
were lost to follow up and 12 out of 50 (24%) were
HIV infected although 29 (58%) of them received formula
feeding.
Characteristics of the 336 women who entered in the
programme before delivery are described in Table 1.T h e
median age was 23 years, and the median height was 152cm.
The proportion of underweight in mothers was 39%, and
approximately half of them were primipara. Almost 40%
were illiterate and only one was smoker. The proportion of
pregnant women with CD4 lymphocyte count below 200
and 350cells/µL were 9% and 29%, respectively. Zidovudine
was used in 76% of women, and nevirapine was used more
frequently than efavirenz. Near 7% initiated ART at the same
day of delivery. Viral load in the third trimester was available
for 199 women and 175 (88%) of them had a viral load
below 1000copies/mL. Seven percent of women delivered
at home, and caesarean section was performed in 39% of
the cases. Zidovudine syrup was used more commonly than
other newborn prophylaxis regimens, and 51% of children
received formula feeding.
In Figure 1,wepresentaﬂowdiagramoftheoutcomesof
allHIV-positivepregnanciesthatenteredinthePMTCTpro-
gramme before delivery. Of the three pregnant women who
had spontaneous abortion, two started ART (zidovudine,4 ISRN Pediatrics
336 HIV-infected pregnant women
307 children alive after
1 week of life
299 children alive after
8 weeks of life
8 children died at age of 1–8 weeks
Of 280 children who had viral load after 6 weeks of age, 5
(1.8%) were HIV infected
318 children were born alive
• 3 spontaneous abortions
￿ 4 voluntary terminations of pregnancy
￿ 11 stillbirths
￿ 12 children lost to follow up
￿ 18 children still on breastfeeding
￿ Of 269 children with known HIV status, 10 (3.7%) were
HIV infected
8 children died at age of 8–52 weeks
Of 127 breastfed children with known HIV status
after stopping breastfeeding and negative initial viral load,
4 (3.1%) children were HIV infected
11 deaths <1 week (5 ﬁrst day)
Figure 1: Flowchart of the outcomes of the study.
lamivudine, and nevirapine) before having the abortion. All
voluntary terminations of pregnancy occurred between the
third and the ﬁfth month of pregnancy. Of the 11 children
who died during the ﬁrst week of life, weight was recorded
in ﬁve and in four of them the birthweight was less than
1.5kg. No mother died during pregnancy or during delivery.
Theperinatalmortalityratewas22/329(67deaths/1000total
births, 95% conﬁdence interval (CI) 45 to 99), the neonatal
mortality rate was 12/318 (38 deaths/1000 live births, 95%
CI 22 to 65), and the infant mortality rate was 27/318 (85
deaths/1000 live births, 95% CI 59 to 121). The overall
transmission of HIV was 3.7% (95% CI, 2 to 6.7), although
12 (4%) were lost to follow up and 18 who had a negative
viral load after six weeks of life were still on breastfeeding
at the end of the study period. Antenatal and perinatal
preventive measures were able to reduce the rate of HIV
transmission to 1.8% (95% CI, 0.7 to 4.1) in those children
who had a viral load determination after the age of six weeks.
Of those breastfed children who had a negative viral load
determinationafteragedsixweeks,3.1%(95%CI,1.2to7.8)
acquired HIV during breastfeeding. In this group, ART was
initiated at least one month before delivery in all but one of
thecases(99.2%).Thecharacteristicsofthetenchildrenwho
became HIV infected are presented in Table 2.
To study the eﬀect of the type of feeding on infant
mortality we excluded children who died during the ﬁrst
week of life to avoid causes of the death related to perinatal
complications [22, 23]. Kaplan-Meier survival curves of
infants by type of feeding are presented in Figure 2.T h r e e
quarters of deaths (12 out of 16) occurred during the ﬁrst
trimester of life. Compared to breastfed children, formula-
fed children had a crude hazard ratio for death of 15.2ISRN Pediatrics 5
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Figure 2: Kaplan-Meier survival curves of infants by type of feeding.
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Figure 3: Proportion of children with severe underweight (<−3Z -
score) and 95% conﬁdence interval during the ﬁrst 18 months of
life by type of feeding.
(95% CI, 2 to 114.8) (P = 0.008). In a multivariable analysis,
the hazard ratio for death in formula-fed children was 13.5
(95% CI, 1.7 to 108.2) (P = 0.014) adjusted by low birth
weight (<2.5kg), low CD4 lymphocyte count of the mother
(<200cells/µL), home delivery, illiteracy of the mother and
less than one month on ART before delivery [24]. The
cumulative mortality at three months was 7.3% (95% CI,
4.1 to 12.7) for formula-fed infants and 0.66% (95% CI,
0.1 to 4.6) for breastfed infants. The cumulative mortality
at 12 months was 9.6% (95% CI, 6.7 to 18.5) for formula
fed infants and 0.68% (95% CI, 0.1 to 4.7) for breastfed
infants. Free-of-HIV survival was also signiﬁcantly higher
in breastfed children (126/131, 96.2%) than in formula-fed
children (130/151, 86.1%) (P = 0.003). When questioning
mothers about the symptoms of the child before death, eight
reported gastrointestinal symptoms, three reported fever,
three reported seizures, one reported respiratory symptoms,
and one reported low consciousness.
The proportion of children with severe underweight
by type of feeding during the ﬁrst 18 months of life is
presented in Figure 3. The proportion of infants with severe
underweight who received formula feeding was higher in
the ﬁrst two months of life, reaching a pick of 40% at
two months, but it was reduced notably afterwards. The
proportion of infants with severe underweight who received
breastfeeding experienced progressive reduction over time.
The mean and 95% CI of anthropometric markers (weight,
length/height, body mass index, weight for length/height,
head circumference, mid-upper arm circumference, triceps
skinfold thickness, and subscapular skinfold thickness) for
age and sex by type of feeding during the ﬁrst 18 months
of life are presented in Figure 4. Whereas biomarkers of
breastfed infants remained more or less stable over time,
formula-fed infants experienced a rapid decline during the
ﬁrst two months of life and a rapid improvement after the
third month of life, achieving similar or superior values to
breastfed infants after the ninth month of life.
4. Discussion
In this study, the use of formula feeding was associated
with increased risk of mortality and lower HIV-free survival
compared to breastfeeding. In India, 98% of children are
breastfed and it is estimated that 54% of all deaths before age
of ﬁve years are related to malnutrition [25]. The introduc-
tion of formula feeding for averting the transmission of HIV
imposes an additional handicap to an already malnourished
population. As it is shown in Figures 3 and 4, formula-
fed children experience an acute decline in anthropometric
markers during the ﬁrst two months of life, when most
of deaths occurred. Our ﬁndings are in accordance with
the results of other studies performed in resource-limited
settings that have shown an increased morbidity and mor-
tality in HIV-exposed children who received formula feeding
[7, 26, 27]. Also in India, HIV-exposed children from a largeISRN Pediatrics 7
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Figure 4: Mean and 95% conﬁdence interval of anthropometric markers during the ﬁrst 18 months of life by type of feeding adjusted by age
and sex.
government hospital who were formula fed had an increased
risk of hospitalization [28].
Although the overall proportion of HIV-infected chil-
drenwas3.7%,prenatalandperinatalinterventionsachieved
a HIV transmission rate of 1.8%, which is similar to the
rate of HIV transmission in developed countries where the
majority of children receive formula feeding [29]. The rate
of HIV transmission due to breastfeeding was 3.1%, which
is slightly higher than the rate reported in clinical trials in
Africa [30, 31].
The breastfed infants were heavier and taller during
the ﬁrst two months, but lighter and shorter thereafter.
Looking at the graph of weight for length/height (a marker
of acute malnutrition) in Figure 4,w ec a no b s e r v ead e c l i n e
after stopping breastfeeding at six months of age compared
to WHO growth standards, which were created from a
population of infants who were breastfed at least until the
age of 12 months [32]. However, we did not observe an
increased mortality in the breastfed group after weaning at
age 5-6 months as it was seen in clinical trials in Africa with
abrupt weaning at the age of four months [33, 34]. This
observation is important because the 2010 WHO guidelines
recommend breastfeeding until the age of 12 months [4],
but the initiation of mixed feeding can increase the risk of
HIV transmission [24]. New studies comparing morbidity,
mortality, and HIV transmission in children who receive
breastfeedingforsixortwelvemonthsmayclarifythismatter.
The proportion of women with underweight was sim-
ilar to the proportion of women from rural areas with
underweightdescribedintheNationalFamilyHealthSurvey,
a large-scale survey conducted in a representative sample
of households throughout India [25]. In the same study,
it was observed that 48% of children under ﬁve years
had stunting (length/height for age < −2Z-scores), 20%
had wasting (weight for length/height < −2Z-scores) and
43% had underweight (weight for age < −2Z-scores).
These data can explain the low values in length/height,
weight for length/height and weight observed in Figure 4.8 ISRN Pediatrics
However, anthropometric markers related to fat deposits
such as triceps and subscapular skinfold thickness had
similar or even higher values than WHO growth standards.
These diﬀerences may be explained by the low quantity of
proteins in the diet in poor and rural areas of India [15, 25].
The study has some limitations. The mother’s ART
was initiated at least one month before delivery in almost
all children who received breastfeeding. It is possible that
the rate of HIV transmission due to breastfeeding will
rise if breastfeeding is encouraged to mothers who initiate
ART late in pregnancy or during labour. New studies are
needed to assess HIV-free survival if breastfeeding is uni-
versally recommended regardless of the time on ART before
delivery.
5. Conclusions
Even in rural areas of India, universal ART to HIV-infected
pregnant women is able to reduce mother-to-child transmis-
sion to less than 5%. Although breastfeeding can increase
the rate of HIV transmission, formula feeding produces mal-
nutrition during the ﬁrst months of life, increases mortality
and, therefore, has lower HIV-free survival compared to
breastfeeding. The results of this study conﬁrm the results of
clinical trials performed in Sub-Saharan Africa and support
the implementation of universal ART regardless of CD4
counttoallHIV-infectedpregnantwomenandbreastfeeding
for all HIV-exposed children in order to achieve WHO
goals of elimination of paediatric HIV without increasing
infant mortality in developing countries with high levels of
malnutrition.
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